GLAND PHARMA
Back to Income Statement
|
GLAND PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹1,269 Cr | ₹1,333 Cr | ₹1,025 Cr | ₹1,510 Cr | ₹1,302 Cr |
What is the latest Operating Profit of GLAND PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2026 | ₹1,269 Cr |
| Mar2025 | ₹1,333 Cr |
| Mar2024 | ₹1,025 Cr |
| Mar2023 | ₹1,510 Cr |
| Mar2022 | ₹1,302 Cr |
How is Operating Profit of GLAND PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,269 Cr | -4.81 | |
| Mar2025 | ₹1,333 Cr | 30.09 | |
| Mar2024 | ₹1,025 Cr | -32.14 | |
| Mar2023 | ₹1,510 Cr | 15.97 | |
| Mar2022 | ₹1,302 Cr | - | |
Compare Operating Profit of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹47,988.6 Cr | -0.5% | 18.7% | 53.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,675.0 Cr | -3% | -2.6% | 21.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,516.0 Cr | -0.5% | 17% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,190.0 Cr | 0.6% | 2.7% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,523.0 Cr | -2.2% | 0.8% | -2.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,493.4 Cr | -1.1% | -1.6% | -0.8% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -0.5% |
18.7% |
53.6% |
| SENSEX | -1% |
0.7% |
-3.6% |
You may also like the below Video Courses